Correlation Between Regen BioPharma and Institute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Institute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Institute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Institute of Biomedical, you can compare the effects of market volatilities on Regen BioPharma and Institute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Institute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Institute.

Diversification Opportunities for Regen BioPharma and Institute

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Regen and Institute is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Institute of Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Institute of Biomedical and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Institute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Institute of Biomedical has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Institute go up and down completely randomly.

Pair Corralation between Regen BioPharma and Institute

Given the investment horizon of 90 days Regen BioPharma is expected to under-perform the Institute. But the pink sheet apears to be less risky and, when comparing its historical volatility, Regen BioPharma is 1.59 times less risky than Institute. The pink sheet trades about -0.21 of its potential returns per unit of risk. The Institute of Biomedical is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  0.42  in Institute of Biomedical on September 2, 2024 and sell it today you would earn a total of  0.53  from holding Institute of Biomedical or generate 126.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Regen BioPharma  vs.  Institute of Biomedical

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Institute of Biomedical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Regen BioPharma and Institute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Institute

The main advantage of trading using opposite Regen BioPharma and Institute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Institute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Institute will offset losses from the drop in Institute's long position.
The idea behind Regen BioPharma and Institute of Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities